08045804946
Send Inquiry
ELEFTHA 150MG
3000.0 INR/Piece
Product Details:
- Life Span Refer to package for expiry date
- Origin of Medicine India
- Packaging Type Vial and box
- Pacakaging (Quantity Per Box) 1 single-use vial per box
- Dosage Form Lyophilized powder for concentrate for solution for infusion
- Indication Treatment of HER2-positive cancers such as breast cancer
- Salt Composition Trastuzumab 150 mg
- Click to View more
X
ELEFTHA 150MG Price And Quantity
- 3000.0 INR/Piece
- 1 Piece
ELEFTHA 150MG Product Specifications
- Adult patients
- 1 single-use vial per box
- Lyophilized powder for concentrate for solution for infusion
- Trastuzumab Lyophilized Powder
- Anticancer, targeted therapy
- Store as instructed on package (typically refrigerated at 2-8C)
- 1 vial
- Vial and box
- For infusion, as prescribed by physician
- Refer to package for expiry date
- India
- Treatment of HER2-positive cancers such as breast cancer
- Prescription, biological drug
- Trastuzumab 150 mg
- 150 mg per vial
- Reconstitute and use as directed by oncologist/physician
- Powder for concentrate
- Each pack contains lyophilized powder and package insert
- 150 mg/vial
- Intravenous (IV) infusion
- Eleftha
- Monoclonal antibody
- Hospital or clinical use as prescribed
Product Description
Discover the astonishing Eleftha 150MG, a preeminent monoclonal antibody designed for targeted therapy in HER2-positive cancers, including breast cancer. Each 150 mg vial contains trastuzumab lyophilized powder, ensuring uncommon precision in hospital or clinical settings. Order today and experience the top standard of care-just reconstitute as directed by your oncologist for intravenous infusion. Every package includes a single-use vial and detailed insert, manufactured in India. Try now and witness the difference in modern, effective anticancer therapy-trusted by healthcare professionals worldwide.
ELEFTHA 150MG: Versatile Clinical Application
ELEFTHA 150MG is specifically developed for use in advanced medical environments such as hospitals, cancer centers, and clinical facilities. This product is administered via intravenous infusion under the supervision of skilled healthcare professionals. Its main application areas include oncology departments, where it's utilized as a part of comprehensive treatment plans for HER2-positive cancers. Designed for adult patients, Eleftha offers flexibility and reliability in any setting that requires top-tier targeted anticancer solutions.
ELFETHA 150MG: Certifications & Global Reach
ELEFTHA 150MG is certified to meet rigorous medical standards, ensuring unparalleled quality for worldwide use. Its packaging features a secure vial and informative box, safeguarding its integrity during logistics and transportation. We offer seamless bulk and individual export solutions to leading markets around the globe. With meticulously managed supply chains, your order is delivered efficiently and in top condition, reflecting our commitment to offer excellence in every aspect of storage, shipment, and distribution.
ELEFTHA 150MG: Versatile Clinical Application
ELEFTHA 150MG is specifically developed for use in advanced medical environments such as hospitals, cancer centers, and clinical facilities. This product is administered via intravenous infusion under the supervision of skilled healthcare professionals. Its main application areas include oncology departments, where it's utilized as a part of comprehensive treatment plans for HER2-positive cancers. Designed for adult patients, Eleftha offers flexibility and reliability in any setting that requires top-tier targeted anticancer solutions.
ELFETHA 150MG: Certifications & Global Reach
ELEFTHA 150MG is certified to meet rigorous medical standards, ensuring unparalleled quality for worldwide use. Its packaging features a secure vial and informative box, safeguarding its integrity during logistics and transportation. We offer seamless bulk and individual export solutions to leading markets around the globe. With meticulously managed supply chains, your order is delivered efficiently and in top condition, reflecting our commitment to offer excellence in every aspect of storage, shipment, and distribution.
FAQ's of ELEFTHA 150MG:
Q: How should ELEFTHA 150MG be administered?
A: ELEFTHA 150MG must be administered as an intravenous infusion after reconstitution, strictly under the supervision of an oncologist or qualified healthcare provider.Q: What conditions is ELEFTHA 150MG used to treat?
A: ELEFTHA 150MG is primarily indicated for the treatment of HER2-positive cancers, especially breast cancer, as prescribed by a physician.Q: When should ELEFTHA 150MG be used in therapy?
A: ELEFTHA 150MG is used as part of a targeted therapy regimen for patients diagnosed with HER2-positive cancers, according to the specific treatment plan outlined by the oncologist.Q: Where can I purchase ELEFTHA 150MG?
A: ELEFTHA 150MG is available through authorized medical suppliers, hospitals, and pharmacies. It is supplied to healthcare facilities and is not intended for direct consumer purchase.Q: What is the process for preparing ELEFTHA 150MG for infusion?
A: To prepare ELEFTHA 150MG, the lyophilized powder must be reconstituted according to instructions provided in the accompanying package insert and administered by a medical professional.Q: What are the benefits of choosing ELEFTHA 150MG?
A: ELEFTHA 150MG offers targeted action against HER2-positive cancer cells, contributing to a more focused and effective anticancer treatment while minimizing effects on healthy tissue.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
